Picard Medical, Inc.

Analysis for Ticker: PMI

Picard Medical Inc manufactures the SynCardia Total Artificial Heart, but its most active operation is the destruction of capital. The company is currently trapped in a state of terminal bleeding, burning 15,6$ million in operating cash every year while facing an accumulated deficit of 72,6$ million. In 04/2026, they reached a point of absolute desperation by taking a 555.555,56$ loan from Quick Capital LLC just to stay alive, but they only received 490.000$ in cash after the lender stripped away original issue fees and an immediate 12% interest charge. Starting 01/07/2026, they must pay back 103.703,70$ every month, which is a mathematical impossibility for a business that loses 204.000$ on its gross production before paying a single salary. It is as if a person with no job borrowed money to pay their rent, but the lender took a huge cut of the cash and then demanded massive monthly payments, all while the borrower's bank account was already empty. The roots of this collapse go back to how the insiders prepared the company to harvest public wealth. In 04/2024, long before the public was involved, the company issued 3,7$ million in notes that let specific investors buy stock at half price later. On 02/07/2024, the board chairman, Richard Fang, and his family funds moved 7$ million in old loans into a new contract that allowed him to buy stock at a 77% discount to whatever price the public eventually paid. Right before the company went public, he donated these heavily discounted notes to the Nexus Science Foundation and Another Dimension Foundation to hide the impact of who was actually pulling the trigger on the upcoming dilution.